Review
Published on 04 Jan 2023
Contribution of natural killer cells in innate immunity against colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1077053
- 7,075 views
- 17 citations
Type at least 3 characters
940 articles
Review
Published on 04 Jan 2023
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1072739
- 3,268 views
- 11 citations
Review
Published on 04 Jan 2023
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1077436
- 4,255 views
- 11 citations
Original Research
Published on 04 Jan 2023
CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1048296
- 3,673 views
- 8 citations
Original Research
Published on 22 Dec 2022
PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1055371
- 3,579 views
- 11 citations
Review
Published on 22 Dec 2022
Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1045481
- 13,125 views
- 13 citations
Case Report
Published on 22 Dec 2022
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1065137
- 2,372 views
- 12 citations
Original Research
Published on 22 Dec 2022
Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1081091
- 4,298 views
- 5 citations
Review
Published on 21 Dec 2022
Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1089320
- 6,233 views
- 10 citations
Original Research
Published on 20 Dec 2022
Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1015850
- 2,355 views
- 3 citations
Original Research
Published on 20 Dec 2022
Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.975980
- 16,041 views
- 22 citations
Methods
Published on 19 Dec 2022
Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.964716
- 2,528 views
- 6 citations
Original Research
Published on 19 Dec 2022
Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1009315
- 2,393 views
- 5 citations
Review
Published on 12 Dec 2022
Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.939356
- 10,495 views
- 7 citations
Review
Published on 08 Dec 2022
The prospect of tumor microenvironment-modulating therapeutical strategies
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1070243
- 5,056 views
- 19 citations
Original Research
Published on 08 Dec 2022
Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1075685
- 3,694 views
- 10 citations